From the Helm: CSL’s David Lamont on the biotech giant’s bright future

Jessica Amir
February 20, 2020

In the latest instalment of Bell Direct’s From the Helm series, Jess has a chat with CSL’s CFO David Lamont.

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Morning Bell 15 April

Jessica Amir
April 15, 2021

Morning Bell 14 April

Jessica Amir
April 14, 2021

Morning Bell 13 April

Jessica Amir
April 13, 2021

Morning Bell 12 April

Jessica Amir
April 12, 2021

Weekly Wrap 9 April

Jessica Amir
April 9, 2021

Morning Bell 9 April

Jessica Amir
April 9, 2021

Morning Bell 8 April

Jessica Amir
April 8, 2021

Morning Bell 7 April

Jessica Amir
April 7, 2021

Morning Bell 6 April

Jessica Amir
April 6, 2021

Morning Bell 1 April

Jessica Amir
April 1, 2021

Morning Bell 31 March

Jessica Amir
March 31, 2021